The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Applied Therapeutics Inc
Portfolio Pulse from
The Schall Law Firm is urging shareholders to participate in a class action lawsuit against Applied Therapeutics Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Investors who bought shares between January 3, 2024, and December 2, 2024, are encouraged to join the lawsuit.
December 29, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The lawsuit against Applied Therapeutics Inc. for alleged securities fraud is likely to create negative sentiment among investors, potentially leading to a decline in the stock price. Legal issues of this nature can cause uncertainty and volatility in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100